1. S., Sowemimo-Coker S. O., Ortolano G. A., Wilkins K., Schaffer J., Wortham S. T. (2006). An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.;Transfusion Medicine Reviews
2. K., Nuttall G. A., Johnson M. E., Dong Y., Sujirattanawimol N., Oliver W. C. Jr., Ereth M. H. (2001). Plasma tranexamic acid concentrations during cardiopulmonary bypass.;Anesthesia and Analgesia
3. A., Carless P. A., Moxey A. J., OConnell D., Stokes B. J., Fergusson D. A., Ker K. (2011). Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.;The Cochrane Database of Systematic Reviews
4. M., Sansom J. E., Harrison P., Warwick J. A., Peachey R. D. (1993). Tranexamic acid (Cyklokapron)-induced fixed-drug eruption.;The British Journal of Dermatology
5. Treatment of traumatic bleeding with recombinant factor VIIa.;Kenet;Lancet,1999